Streetbeat News

Equity Actions

LSH

Lakeside's IPO is indicating a price of $5.30 per share, but it has been priced at $4.50 per share for 1.5 million shares.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 2:02 pm

LSH

Lakeside's IPO is indicating a price of $5 per share on 80,325 shares, while the IPO is priced at $4.50 per share on 1.5 million shares.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 1:58 pm

LSH

Trading halt status for an IPO security was updated at 9:50:00 AM ET, and the security has been released for quotation.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 1:50 pm

BUD

TLRY

Tilray Brands (NASDAQ:TLRY) has been valued at $2 billion and is seen as having a $10 billion market opportunity. Analyst Pablo Zuanic has initiated coverage with a 'Neutral' rating, citing potential in global markets and U.S. federal legalization. Tilray's diversified portfolio includes beverages and wellness products, and it has invested in the U.S. market through debt holdings in MedMen. The company recently announced a $250 million equity offering to support its U.S. strategy. Despite challenges in the Canadian market, Tilray's international operations and strategic focus could significantly increase its market valuation.

Portfolio Pulse from Nicolás Jose Rodriguez

June 28, 2024 | 1:50 pm

APVO

Aptevo Therapeutics Inc. (NASDAQ:APVO) announced a $2.75M offering of 5,339,806 shares of its common stock or pre-funded warrants and warrants to purchase up to 10,679,612 shares at $0.515 per share. The offering is expected to close around July 1, 2024, with Roth Capital Partners and Dawson James Securities, Inc. acting as agents. The proceeds will be used for clinical development, working capital, and general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 1:23 pm

NLSP

NLS Pharmaceutics announced a registered direct offering of 3,277,750 shares at $0.24 per share.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 1:22 pm

CING

Cingulate Inc. (NASDAQ:CING) announced the exercise of Series A and B warrants, generating $1.86M in gross proceeds. The exercise price was reduced to $0.585 per share. New Series C and D warrants will be issued, with different expiration dates.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 1:16 pm

TCX

Tucows has appointed Ivan Ivanov as its new Chief Financial Officer (CFO).

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 1:11 pm

ALUR

Allurion Technologies, Inc. (NYSE: ALUR) announced a public offering of 14,406,508 shares of its common stock at $1.20 per share, raising $17.3 million. Additionally, a $2.7 million private placement with RTW Investments will bring total proceeds to $20 million. The offering is expected to close around July 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 1:08 pm

IZEA

IZEA Worldwide, Inc. has authorized a $5 million share repurchase program. This move indicates the company's confidence in its financial health and future prospects.

Portfolio Pulse from Benzinga Newsdesk

June 28, 2024 | 1:02 pm